The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pulmonary nodulosis
Publications
Methotrexate-induced Accelerated Pulmonary Nodulosis.
American journal of respiratory and critical care medicine. 2015;192(2):252-3
Multiple pulmonary nodules in a male with psoriatic arthritis.
European respiratory review : an official journal of the European Respiratory Society. 2010;19(116):164-5
Accelerated pulmonary nodulosis and sterile pleural effusion in a patient with psoriatic arthropathy during methotrexate therapy: a case report.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2009;15(1):29-30
Bilateral hydropneumothoraces in a patient with pulmonary rheumatoid nodules during treatment with methotrexate.
Annals of the rheumatic diseases. 2005;64(11):1661-2
Methotrexate induced accelerated nodulosis.
The Journal of the Association of Physicians of India. 2004;52:538-40
Accelerated nodulosis during methotrexate therapy for refractory rheumatoid arthritis. A case report.
Advances in experimental medicine and biology. 1999;455:521-4
Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases.
The Journal of rheumatology. 1992;19(6):867-71